T cell-dependent antibody responses are a pillar of adaptive immunity; they constitute protective responses to a wide variety of pathogens, form the basis of the immunological memory induced by the vast majority of effective vaccines and underlie the pathogenesis of many autoimmune and allergic disorders 1,2 . Follicular helper T cells (T FH cells) are a subset of CD4 + T cells specialized to provide signals that induce the growth, differentiation, immunoglobulin isotype switching, affinity maturation and antibody secretion of B cells 1 . They are defined by Bcl-6, a transcriptional repressor that is necessary and sufficient to direct T FH cell differentiation [3] [4] [5] , and by abundant expression of the chemokine receptor CXCR5 and the immunoregulatory receptor PD-1 (ref. 1). T FH cell differentiation begins very early in the immune response, coincident with rapid proliferation that expands the pool of responding cells. Expression of Bcl-6 is induced very early during T cell activation and is further upregulated in developing T FH cells 6 in conjunction with upregulation of CXCR5 expression and downregulation of CCR7 expression 7 . Such changes in the expression of homing receptors allow developing T FH cells to migrate to the boundary between the T cell zone and B cell follicles of secondary lymphoid organs, where they encounter antigen-specific B cells 1 . Continued cognate interactions with antigen-presenting B cells in the germinal centers (GCs) of lymphoid follicles further polarize T FH cells 8 and help to maintain the T FH cell phenotype 9 .
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T cell-dependent antibody responses are a pillar of adaptive immunity; they constitute protective responses to a wide variety of pathogens, form the basis of the immunological memory induced by the vast majority of effective vaccines and underlie the pathogenesis of many autoimmune and allergic disorders 1, 2 . Follicular helper T cells (T FH cells) are a subset of CD4 + T cells specialized to provide signals that induce the growth, differentiation, immunoglobulin isotype switching, affinity maturation and antibody secretion of B cells 1 . They are defined by Bcl-6, a transcriptional repressor that is necessary and sufficient to direct T FH cell differentiation [3] [4] [5] , and by abundant expression of the chemokine receptor CXCR5 and the immunoregulatory receptor PD-1 (ref. 1) . T FH cell differentiation begins very early in the immune response, coincident with rapid proliferation that expands the pool of responding cells. Expression of Bcl-6 is induced very early during T cell activation and is further upregulated in developing T FH cells 6 in conjunction with upregulation of CXCR5 expression and downregulation of CCR7 expression 7 . Such changes in the expression of homing receptors allow developing T FH cells to migrate to the boundary between the T cell zone and B cell follicles of secondary lymphoid organs, where they encounter antigen-specific B cells 1 . Continued cognate interactions with antigen-presenting B cells in the germinal centers (GCs) of lymphoid follicles further polarize T FH cells 8 and help to maintain the T FH cell phenotype 9 .
Beyond their established role in orchestrating humoral immunity, T FH cells and transient T FH -like transition states of activated CD4 + T cells have been linked to T helper type 1 (T H 1) differentiation 10, 11 and the generation of memory helper T cells 12, 13 .
MicroRNAs (miRNAs) have emerged as important regulators of many aspects of the differentiation and function of cells of the immune system 14 . The fates of activated helper T cells are very sensitive to precise 'dosing' of regulatory factors 10 and are therefore subject to regulation by the fine-tuning activity of miRNAs. There is some evidence that miRNAs regulate the T FH cell gene-expression program 5 and the plasticity of T FH cells 15 . However, the contribution of miRNAs to T FH cell differentiation and function remains largely unknown.
Here we show that global miRNA expression in CD4 + T cells was absolutely required for the differentiation of T FH cells in vivo, independently of any proliferative defects associated with miRNA deficiency. Furthermore, we found that the miR-17~92 cluster was particularly important for robust T FH cell responses. In a proteinimmunization model, miR-17~92 contributed to the differentiation of an early CXCR5 hi Bcl-6 hi T FH cell population, in part by targeting the mRNA that encodes the tumor suppressor PTEN. In a viral infection model, miR-17~92 repressed the expression of genes encoding molecules associated with the function of other helper T cell subsets but 'inappropriate' and not normally expressed in T FH cells. We identified A r t i c l e s and confirmed Rora (which encodes the transcription factor RORα) as a direct target of miR-17~92 that contributed to the substantial phenotypic changes observed. We conclude that miRNAs are important regulators of the differentiation and function of T FH cells.
RESULTS

The differentiation and function of T FH cells requires miRNAs
To investigate the global role of miRNAs in the differentiation and function of T FH cells, we obtained naive, congenically marked (CD45.2 + ) CD4 + T cells from mice that are deficient in the miRNAbiogenesis factor DGCR8 and are thus deficient in miRNAs (CD4-Cre + Dgcr8 fl/fl ; called 'Dgcr8 ∆/∆ ' here), with transgenic expression of the OT-II ovalbumin (OVA)-specific T cell antigen receptor (TCR), and from their control, miRNA-sufficient (CD4-Cre + Dgcr8 +/fl ; called 'Dgcr8 +/∆ ' here) OT-II counterparts. We transferred those cells into CD45.1 + wild-type recipient mice and subsequently immunized the recipients with OVA. Considerably fewer miRNA-deficient OT-II cells than control OT-II cells accumulated in the draining lymph nodes 4.5 d after immunization (Fig. 1a) . Among the remaining Dgcr8 ∆/∆ OT-II cells, the frequency of PD-1 hi CXCR5 hi T FH cells was much lower than that among the transferred control cells (Fig. 1a) , whereas the frequency of endogenous T FH cells was very similar in both sets of recipients ( Supplementary Fig. 1a) . The diminished generation of T FH cells resulted in significantly lower relative and absolute numbers of Fas + Bcl-6 + GC B cells (Fig. 1b) . Thus, T cell-intrinsic miRNAs were critical for T FH cell responses and GC formation.
To distinguish between impaired proliferation and a potential intrinsic defect in T FH cell differentiation, we tracked the generation of T FH cells according to the number of cell divisions in the adoptivetransfer model 6 . The miRNA-deficient OT-II cells proliferated less than did their control, miRNA-sufficient (CD4-Cre + Dgcr8 +/+ ; called 'Dgcr8 +/+ ' here) OT-II counterparts ( Fig. 1c and Supplementary  Fig. 1b) . Early induction of Bcl-6 expression was similar in miRNA-deficient and control cells, as all proliferating cells upregulated Bcl-6 expression ( Fig. 1c and Supplementary Fig. 1b , Dgcr8 ∆/∆ versus unimmunized). However, miRNAs were critical for further upregulation of Bcl-6 expression in developing T FH cells as they continued to proliferate (Fig. 1c , Dgcr8 ∆/∆ versus Dgcr8 +/+ ). In addition, miRNA-deficient T cells completely failed to upregulate CXCR5 expression, sustained abnormally high CCR7 expression, failed to accumulate in proximity to B cells at the boundary between the T cell and B cell zones and did not enter B cell follicles ( Fig. 1c and Supplementary Fig. 1b-e) . Thus, miRNAs were essential for the differentiation and function of T FH cells.
Regulation of T FH cell and GC responses by miR-17~92
Very little is known about the functions of specific miRNAs in T FH cells. A published report has proposed that Bcl-6 inhibits miR-17~92 expression to prevent it from directly repressing CXCR5 expression 5 , which would interfere with T cell migration and inhibit the generation and function of T FH cells. However, T cell activation induces miR-17~92 expression 16, 17 , and overexpression of miR-17~92 in lymphocytes leads to a lupus-like autoimmune syndrome with high antibody titers, which suggests enhanced T FH cell function 18 . To directly determine whether miR-17~92 inhibits or promotes the generation of T FH cells, we infected mice lacking miR-17~92 only in T cells (with loxP-flanked alleles encoding miR-17~92 (Mirc1 fl/fl ) deleted by Cre recombinase expressed from the T cell-specific Cd4 promoter (CD4-Cre + Mirc1 fl/fl ); called 'T17~92 ∆/∆ ' here) or their control counterparts with sufficient miR-17~92 in T cells (CD4-Cre + Mirc1 +/+ or CD4-Cre − Mirc1 fl/fl ; collectively called 'T17~92 +/+ ' here) with lymphocytic choriomeningitis virus (LCMV), Armstrong strain. Infected T17~92 ∆/∆ mice had considerably fewer splenic T FH cells than did T17~92 +/+ mice and had severe impairment in the generation of GC B cells (Fig. 2a) . Infected T17~92 ∆/∆ mice also had overall lower spleen cellularity and frequency of activated (CD44 hi ) T cells than Fig. 2a,b) . Although T17~92 ∆/∆ mice also lacked miR-17~92 in cytotoxic CD8 + T cells, which mediate LCMV clearance at this stage of disease, viral clearance was similar at day 8 after infection in T17~92 ∆/∆ and T17~92 +/+ mice (data not shown). Thus, the impaired antiviral T FH response was not an indirect consequence of diminished clearance of the virus. Of note, deletion of one copy of the miR-17~92 cluster in mice (CD4-Cre + Mirc1 +/fl ; called 'T17~92 +/∆ ' here) resulted in an intermediate phenotype ( Fig.  2a and Supplementary Fig. 2a,b) . By using immunization with nitrophenyl (NP)-OVA protein as a second, noninfectious model, we confirmed that miR-17~92 expressed by T cells was required for T FH cell differentiation and was indirectly required for the formation of GC B cells (Fig. 2b) . Again, the deletion of one copy of the miR-17~92 cluster in T17~92 +/∆ mice resulted in an intermediate phenotype (Fig. 2b) . In contrast to results obtained with the LCMV model, the cellularity of draining lymph nodes and the frequency of activated T cells were similar in T17~92 ∆/∆ and T17~92 +/+ mice ( Supplementary Fig. 2c,d ), which indicated a specific defect in the generation of T FH cells. That defect also resulted in delayed and significantly lower titers of NP-specific antibody (Fig. 2c) , and we observed a similar trend for antibody responses to LCMV (Supplementary Fig. 2e ). In summary, T cell-intrinsic miR-17~92 was required for optimal T FH cell and GC responses, including the production of antigen-specific antibodies.
Robust T FH cell differentiation depends on miR-17~92
Although overexpression of miRNAs of the miR-17~92 cluster promotes T cell proliferation [17] [18] [19] , adoptively transferred naive OT-II cells derived from T17~92 ∆/∆ donor mice (called '17~92 ∆/∆ OT-II' here) or from T17~92 +/∆ donor mice (called '17~92 +/∆ OT-II' here) had only slightly less proliferation (17~92 ∆/∆ OT-II) or unchanged proliferation (17~92 +/∆ OT-II) relative to that of their miR-17~92-sufficient control counterparts (OT-II cells derived from T17~92 +/+ donor mice; called '17~92 +/+ OT-II' here; Fig. 3a and Supplementary  Fig. 3a) . Polyclonal CD4 + T cells from T17~92 ∆/∆ mice also proliferated slightly less than control cells from T17~92 +/+ mice did when activated by costimulation with small amounts of antibody to CD28 (anti-CD28) in vitro. However, that defect was overcome by an increase in the amount of costimulation with anti-CD28 (Supplementary Fig. 3b) . Thus, the miR-17~92 cluster was largely dispensable for T cell proliferation under these conditions, possibly due to partial compensation by the closely related miR-106a~363 and miR-106b~25 clusters.
In contrast, transferred miR-17~92-deficient (17~92 ∆/∆ OT-II) cell populations had a much lower frequency and total number of Bcl-6 hi CXCR5 + developing T FH cells (Fig. 3b) . Tracking the early generation of T FH cells showed a differentiation defect that was independent of cell division. Upregulation of the expression of both Bcl-6 and CXCR5 was impaired in 17~92 ∆/∆ OT-II cells, which resulted in a much smaller proportion of Bcl-6 + CXCR5 + developing T FH cells at each cell division than among their miR-17~92-sufficient (17~92 +/+ OT-II) control counterparts (Fig. 3c,d and Supplementary Fig. 3c ). The defective T FH differentiation of 17~92 ∆/∆ OT-II cell populations was also reflected by their lower frequency of interleukin 21 (IL-21)-producing cells (Fig. 3e) and much greater frequency of dividing CXCR5 − cells expressing the high affinity IL-2 receptor α-chain CD25 (Fig. 3f) , which inhibits T FH differentiation 20, 21 . The generation of T FH cells was also lower among 17~92 +/∆ OT-II cells ( Supplementary  Fig. 3d ), which indicated that miRNAs of the miR-17~92 cluster were limiting factors for T FH cell differentiation. In summary, 17~92 ∆/∆ CD4 + T cells had a T FH cell-differentiation defect similar to that of cells that lack all miRNAs, which emphasized the prominent functional importance of this miRNA cluster.
Overexpression of miR-17~92 promotes T FH cell generation
Consistent with the idea that T FH cell differentiation depends on miR-17~92, adoptively transferred OT-II cells overexpressing the miR-17~92 cluster in the form of a human transgene (CD4-Cre + Rosa26-Mirc1 tg/tg ; called '17~92 tg/tg ' here) showed enhanced generation of T FH cells relative to that of OT-II cells with normal expression of miR-17~92, without substantially greater proliferation after immunization with NP-OVA ( Fig. 4a-d) . In unimmunized mice A r t i c l e s heterozygous for the miR-17~92-overexpressing transgene only in T cells (CD4-Cre + Mirc1 tg/+ ; called 'T17~92 tg/+ ' here), the number of endogenous polyclonal T FH cells was also much greater in Peyer's patches, with a correspondingly greater abundance of GC B cells, relative to that of their T17~92 +/+ counterparts with normal expression of miR-17~92 (Fig. 4e) . Although T17~92 tg/+ mice had a generally greater abundance of total B cell and CD4 + T cell numbers, GC B cells and T FH cell populations were 'preferentially' expanded. Finally, the abundance of CXCR5 hi PD-1 hi Foxp3 + follicular regulatory T cells (T reg cells) correlated with the miR-17~92 'dose' , but the abundance of polyclonal T reg cells did not ( Supplementary Fig. 4 ), which suggested that among all T reg cells, the subset of T reg cells located in GCs (follicular T reg cells) were particularly sensitive to regulation by miR-17~92. Thus, artificially increasing the amount of miR-17~92 enhanced T FH cell differentiation, and constitutive overexpression of miR-17~92 led to the accumulation of T FH cells.
Repression of Pten by miR-17~92 early in T FH cell differentiation
Pten is reported to be an important target of miR-17~92 that contributes to miR-17~92-overexpressing disease models of autoimmunity and lymphomagenesis 18, 22, 23 . We found higher PTEN expression in all responding 17~92 ∆/∆ OT-II cells than in their 17~92 +/+ OT-II counterparts at 48 h after immunization of wild-type recipient mice with NP-OVA ( Supplementary Fig. 5a ), and especially in the first few cell divisions at later time points (Supplementary Fig. 5b ). Conversely, 17~92 tg/tg OT-II cells had lower PTEN expression than did their 17~92 +/+ OT-II counterparts (Supplementary Fig. 5c ). To assess the functional relevance of miR-17~92-mediated repression of PTEN, we limited Pten to one allele. Deletion of one allele of Pten resulted in lower PTEN expression (Supplementary Fig. 5d ) and partially restored induction of the expression of Bcl-6 and CXCR5 in early cell divisions of 17~92 ∆/∆ Pten +/∆ OT-II cells (Supplementary Fig. 5e ). However, 17~92 ∆/∆ Pten +/∆ and 17~92 ∆/∆ Pten +/+ OT-II cell populations had a similar frequency of Bcl-6 + CXCR5 + cells among those cells that had proliferated the most (Supplementary Fig. 5e ), which suggested substantial contributions from additional targets.
Repression of T FH cell-inappropriate genes by miR-17~92
Although the repression of individual miRNA target genes is generally modest, the aggregate biological effect can be large 24, 25 . To obtain a sufficient number of T FH cells for genome-wide transcript analysis, we transferred SMARTA CD4 + T cells, which have transgenic expression of a LCMV-specific TCR, derived from T17~92 +/+ donor mice (called '17~92 +/+ SM' here) or T17~92 ∆/∆ donor mice (called '17~92 ∆/∆ SM' here), into wild-type recipient mice, infected the recipients with LCMV and then purified donor-derived T FH cells for microarray analysis (Fig. 5a) . We recovered fewer 17~92 ∆/∆ SM T FH cells than 17~92 +/+ SM T FH cells from infected recipient mice in this system, which was due to a proportional overall lower abundance of 17~92 ∆/∆ SM cells (Supplementary Fig. 6 ). Genome-wide transcript analysis showed that as a group, expression of predicted mRNA targets 26 of each miRNA family in the miR-17~92 cluster was derepressed in 17~92 ∆/∆ SM T FH cells (Fig. 5b) . In contrast, expression of predicted miR-29 targets shown before to be actively repressed by miR-29 in T cells 19 npg A r t i c l e s but in only a few CXCR5 − 17~92 ∆/∆ SM non-T FH cells (Fig. 5a,d) .
Most of those non-T FH cells were T-bet hi T H 1 cells (data not shown).
We confirmed additional gene dysregulation in T FH cells by quantitative PCR. Il1r1 and Rora were derepressed in 17~92 ∆/∆ SM T FH cells (Fig. 5e) . Ex vivo restimulation of 17~92 +/+ SM and 17~92 ∆/∆ SM cells also resulted in a greater proportion of IL-22 + IL-17A − cells and, to a lesser extent, IL-22 + IL-17A + cells, but not a greater proportion of cells producing only IL-17A in 17~92 ∆/∆ SM than in their 17~92 +/+ SM counterparts (Fig. 5f) . Thus, miR-17-92 repressed Ccr6, Il1r2, Il1r1, Rora and Il22 during T FH cell differentiation in infection with LCMV. However, it remained unclear if those genes were directly targeted by miR-17~92 or whether the observed dysregulation was an indirect effect.
Rora is a functionally relevant miR-17~92 target Because the transcription factor RORα (encoded by Rora) is sufficient to induce IL-1R1 expression 27 and CCR6 expression 28 , and IL-1R1 expression partially depends on RORα 27 , we considered the possibility that unrestrained RORα expression may have accounted for part of the observed subset-inappropriate gene expression in 17~92 ∆/∆ SM T FH cells. The 3′ untranslated region of Rora has two clusters of predicted miRNA-binding sites, each with four conserved miR-17~92-binding sites (Supplementary Fig. 7) . Transfection of 17~92 +/+ OT-II and 17~92 ∆/∆ OT-II cells with luciferase reporter constructs showed that endogenous miR-17~92 repressed both clusters, whereas miR-17~92-overexpressing (17~92 tg/tg ) OT-II cells had enhanced repression (Fig. 6a) . We isolated the effect of each miRNA by transfecting polyclonal miRNA-deficient (Dgcr8 ∆/∆ ) CD4 + T cells with reporter constructs and individual miRNA mimics. This analysis showed perfect correlation between target-site predictions and repressive activity of the corresponding miRNAs (Fig. 6b) . We concluded that all four miRNA families of the miR-17~92 cluster contributed to robust inhibition of Rora expression.
To assess the functional relevance of miR-17~92-mediated repression of Rora in vivo, we limited Rora to one functional allele by intercrossing T17~92 ∆/∆ SMARTA mice and staggerer mice, which have a spontaneously mutated allele (Rora sg ) that does not encode a functional RORα protein. Rora heterozygosity (Rora +/sg ) in 17~92 ∆/∆ SM T FH cells restored Rora mRNA to the abundance observed in 17~92 +/+ SM T FH cells (Supplementary Fig. 8 ). Adoptive transfer of 17~92 ∆/∆ Rora +/+ SM cells into wild-type mice, followed by infection of the recipients with LCMV, led to higher expression of CCR6 and IL-1R2 than that of their 17~92 +/+ Rora +/+ SM counterparts mainly in T FH cells (Fig. 6c) , which confirmed our results reported above (Fig. 5d) . In contrast, many fewer 17~92 ∆/∆ Rora +/sg SM cells than 17~92 ∆/∆ Rora +/+ SM cells had higher CCR6 expression than that of their 17~92 +/+ Rora +/+ SM counterparts (Fig. 6c) . Thus, limiting Rora to one functional allele partially restored proper regulation of CCR6 despite the absence of miR-17~92. Notably, 17~92 +/+ Rora +/+ SM, 17~92 ∆/∆ Rora +/+ SM and 17~92 ∆/∆ Rora +/sg SM T FH cells showed no difference in expression of the closely related transcription factor RORγt, which can also induce CCR6 expression (Fig. 6d) . Microarray experiments also indicated no difference between 17~92 +/+ SM and 17~92 ∆/∆ SM T FH cells in RORγt expression (data not shown). Thus, it is unlikely that RORγt was the driving force behind the dysregulated gene signature of 17~92 ∆/∆ SM T FH cells. IL-1R2 expression was not affected by limiting Rora to one functional allele (Fig. 6c) . In contrast, the frequency of IL-22-producing cells among 17~92 ∆/∆ Rora +/sg SM cells was about half that of 17~92 ∆/∆ Rora +/+ SM cells (Fig. 6e) . We concluded that miR-17~92 was needed to directly repress Rora during T FH cell differentiation to prevent subset-inappropriate gene expression. 
DISCUSSION
Better understanding of the genetic programs that regulate the differentiation and plasticity of T FH cells might lead to new strategies for rational vaccine design and suppression of antibody-mediated autoimmune diseases. Major advances delineating important roles for Bcl-6 and other proteins have been achieved 1 . In contrast, very little is known about the roles of miRNAs in T FH cell differentiation. We found that miRNAs were absolutely critical for the differentiation and function of T FH cells and that the miR-17~92 cluster in particular was required for robust T FH cell responses in a T cell-intrinsic manner. Those SMARTA T FH cells that did develop in the absence of miR-17~92 failed to suppress the direct target Rora and a 'suite' of other T FH cell-inappropriate genes normally expressed by the T H 17 and T H 22 subsets of helper T cells. We conclude that miR-17~92 promotes T FH cell differentiation and maintains the fidelity of T FH cell identity by repressing non-T FH cell genes both directly and indirectly. Together with published studies showing that miR-17~92 regulates the proliferation and survival of T cells [17] [18] [19] , our findings indicate that miR-17~92 constitutes a central coordinator of the fate of activated T cells. The global roles of miRNAs in T FH cell responses have been difficult to study because of the substantial defects in the survival and proliferation of miRNA-deficient T cells. We overcame that roadblock by adoptive transfer of OVA-specific OT-II T cells and by using dilution of intravital dye to analyze the early stages of the T FH differentiation of miRNA-sufficient and miRNA-deficient cells that had survived and divided the same number of times in vivo. This approach showed that miRNAs were essential for the earliest steps in the differentiation into T FH cells, including upregulation of the expression of Bcl-6 and CXCR5, downregulation of the expression of CCR7 and migration to sites of interaction with B cells in secondary lymphoid organs. Those findings were in contrast to the requirement for miRNAs to restrain T H 1 differentiation 19, 29 but were reminiscent of the requirement for miRNAs in supporting the differentiation and function of T reg cells [30] [31] [32] .
The same transfer system described above showed that miR-17~92 regulated various activities of T cells that are important for mounting effective humoral immune responses. We found an unexpectedly small effect of miR-17~92 on the proliferation of OT-II T cells in vivo, but it was required for optimal T FH cell differentiation. Higher expression of Pten, a known direct target of miR-17~92 that encodes a regulator of T FH cell responses 18, 33 , partially accounted for the defective generation of T FH cells during the earliest cell divisions. Notably, costimulation via CD28 represses PTEN expression 34 and induces miR-17~92 expression in activated T cells 16, 35 . We speculate that the required role of costimulation via CD28 in T FH cell differentiation 36 may be mediated in part by induction of miR-17~92 expression and subsequent downregulation of PTEN expression. However, the effect of Pten regulation was barely detectable in this system, which indicates important roles for other direct targets of miR-17~92. Cell proliferation and the early induction of Bcl-6 expression that occurs in all activated T cells 6 was intact in the absence of miR-17~92. Those observations indicated that some of the relevant targets must affect T FH cell differentiation itself rather than T cell activation in general. 
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In contrast, the further upregulation of Bcl-6 expression in dividing cells characteristic of T FH cells was considerably blunted, and the induction of CXCR5 expression was almost completely abrogated. We also observed specific effects on T FH cell differentiation that could be distinguished from general activation defects during LCMV infection. We noted that miR-17~92 deficiency did not affect the frequency of SMARTA T FH cells but did result in a significantly lower total number of both T FH cells and T H 1 cells in infected spleens. Thus, infection with LCMV, which induces extremely robust T cell population expansion, resulted in a defect in antigen-driven helper T cell proliferation in vivo predicted by published in vitro studies 18, 19 , whereas the more slowly proliferating OT-II T cells manifested a more selective defect in T FH cell differentiation. Polyclonal responses in T17~92 ∆/∆ mice also differed in the magnitude of the defect in the frequency and number of T FH cells (affected more during infection with LCMV) and GC B cells (affected more after immunization with OVA). Compromised function of CD8 + T cells, which also lack miR-17~92 in these mice, may indirectly affect these responses, particularly in the case of infection with LCMV 40 .
CD4 + helper T cell 'plasticity' has garnered considerable attention recently. The present models of T cell differentiation suggest that cell identity is less rigid than previously thought 41 . Although Bcl-6 has been identified as a subset-defining transcription factor required for T FH cell differentiation [3] [4] [5] , it remains controversial whether or not T FH cells represent a stable cell lineage 1 . A new model suggests that initial helper T cell differentiation proceeds via a Bcl-6 + pre-helper T cell stage with concurrent upregulation of expression of the subsetdefining transcription factors T-bet, GATA-3 and/or RORγt 42 . According to this model, T H 1-, T H 2-or T H 17-differentiation cues downregulate Bcl-6 expression and further upregulate expression of the subset-defining factors. In contrast, higher Bcl-6 expression and suppression of RORγt, GATA-3 and T-bet yields T FH cells. As concomitant expression of competing transcription programs is common, repression of genes encoding molecules that lead to alternative cell fates is an important requirement during T cell differentiation 10, 43 . Individual miRNAs can be powerful enough to shift a cell's transcriptome to that of a different cell type 44 , and they maintain the fidelity of cell type-specific transcriptomes by repressing genetic programs of other cell lineages 45 . Deficiency in miRNAs induces proinflammatory cytokine secretion in T reg cells even when they continue to 47 . The unexpected identification of Rora as a direct target of miR-17~92 and of RORα as a functionally relevant contributor to T FH cellinappropriate gene expression suggests that differentiating (pre-)T FH cells receive signals that induce Rora transcription but that miR-17~92 renders such induction inconsequential. Additional studies are needed to identify those signals and to determine whether miR-17~92 controls Rora expression in other cell types as well. A 'lineage-defining' transcription factor has not been identified for T H 22 cells, but we note that despite their similarity to T H 17 cells, human T H 22 cells do not require RORγt expression 37 . In line with that, RORγt expression was not affected in the hybrid T FH -T H 17-T H 22 signature we noted in 17~92 ∆/∆ SM T FH cells. Moreover, the heterogeneity of T H 17 cells poses specific challenges, and certain types of T H 17 cells might be more closely related to T H 22 cells than to conventional T H 17 cells 39 . Thus, the distinct functions of RORα and RORγt in differentiating T cells might need to be revisited. In addition, it remains uncertain whether altered migration, response to cytokines or some other trait of RORα-expressing cells limits the differentiation and function of T FH cells in vivo. Additional studies are needed to define miR-17~92 function in the determination of early T FH cell fate and to delineate cell-intrinsic effects on the molecular program from secondary effects due to altered abilities to sense the environment. Finally, we note that our data demonstrated that regulation of RORα only partially explained the hybrid gene-expression profile of miR-17~92-deficient T FH cells. Additional direct targets relevant to this phenotype must exist and remain to be discovered. Nevertheless, our findings indicate that miR-17~92 and Bcl-6 act together to 'imprint' and protect the identity of developing T FH cells by repressing differentiation into alternative T cell subsets.
METHODS
Methods and any associated references are available in the online version of the paper. Accession code. GEO: microarray data, GSE42760. Immunohistochemistry. Draining popliteal lymph nodes were dissected, embedded in Tissue-Tek optimum cutting temperature compound (Sakura Finetek) and 'flash-frozen' in liquid nitrogen. Frozen tissues were stored at −80 °C until further processing. Cryosections (7 µm in thickness) were air-dried for 1 h before and after fixation in cold acetone for 10 min, then were rehydrated for 10 min in Tris-buffered saline (TBS), pH 7.6, containing 0.1% BSA. Slides were stained for 3 h at 20-25 °C in a humidified chamber in TBS containing 0.1% BSA, 1% normal mouse serum and 1% normal rat serum with a mixture of the following diluted primary antibodies: fluorescein isothiocyanateconjugated anti-CD45.2 (104; Biolegend) and polyclonal goat antibody to mouse IgD (GAM/IGD(FC)/7S; Cedarlane Labs). After being washed for 5 min in TBS, slides were incubated for 1h with cocktails of the following secondary reagents in 0.1% BSA in TBS: alkaline phosphatase-conjugated mouse antibody to fluorescein isothiocyanate (200-052-037; Jackson ImmunoResearch), horseradish peroxidase-conjugated polyclonal donkey antigoat (705-035-147; Jackson ImmunoResearch) and streptavidin-horseradish peroxidase. Enzyme conjugates were developed with DAB and Fast-blue (both from Sigma-Aldrich).
Statistics. Data were analyzed with Prism 5 (GraphPad Software). The twotailed non-parametric Mann-Whitney test was used for comparison of two unpaired groups. The nonparametric Kruskal-Wallis test was used for comparison of three or more unpaired groups, followed by Dunn's post-hoc test for calculation of the P value for each group. Two-way analysis of variance was used together with Bonferroni post-hoc tests for comparison of replicates in each cell division of CTV-labeled OT-II cells.
